Cytonix

Startups QuantaLife and Inostics join more established outfits RainDance Technologies and Life Technologies in exploring the digital PCR market, but all players will need to negotiate what is sure to be a complex intellectual property landscape.

Digital PCR may be on the verge of becoming nearly as ubiquitous as its predecessor, quantitative real-time PCR, thanks to the integration of empowering nanoscale and microfluidic technologies.

ABI's recently launched MeltDoctor HRM kits are among a series of moves that the company is making to expand its PCR business in the clinical market, an ABI official told GenomeWeb Daily News.

Life Technologies disclosed the acquisition in its second-quarter earnings release. It said that it bought the firm for its intellectual property related to its microfluidics-based digital polymerase chain reaction technology.

A phylogenetic analysis indicates two venomous Australian spiders are more closely related than thought, the International Business Times reports.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.

In Science this week: CRISPR-based approach for recording cellular events, and more.

A new company says it will analyze customers' genes to find them a suitable date, though Smithsonian magazine says the science behind it might be shaky.